Please select the eligibility criteria that correspond to the clinical trial below.
Title: Program of TCM on Early Rehabilitation and Secondary Prevention of Ischemic Stroke
Brief Summary: Complex project of Traditional Chinese Medicine (TCM) with Western Medicine (WM) project under stroke unit mode contrast,assuming that the efficiency of TCM on early rehabilitation and secondary prevention of ischemic stroke is same or better than that of WM.


Options:
A: This study will be set up in COPD patients with CHRF who were referred to our centre to start chronic NIV.

Inclusion criteria:

* Indication to initiate chronic NIV in COPD patients (GOLD stage III or IV: FEV1/ forced vital capacity (FVC)\< 70% and FEV1\< 50% predicted; PaCO2 \> 6.0 kPa in stable condition, which means no COPD exacerbation for 4 weeks and a pH \> 7.35)
* Age \> 18 years
* Existence of a sufficient social support network making initiation of HMV at home possible and safe.

Exclusion Criteria:

* Instable severe cardiac comorbidities (left ventricular ejection fraction below 45%, instable angina pectoris complaints)
* Patients admitted to a nursing home
B: Inclusion Criteria:

* Acute exacerbation of chronic heart failure,
* Age over 75,
* Appropriate care supervision at home,
* Telephone connection,
* Living in the hospital-at-home catchment area and informed consent.

Exclusion Criteria:

* Absence of family and social support;
* Patients who need mechanical ventilation,
* Severe dementia,
* End-stage cancer,
* History of severe renal impairment or hepatic failure with ascitis.
C: Inclusion Criteria:

* According with the stroke diagnosis of Traditional Chinese Medicine
* According to atherosclerotic thrombotic cerebral infarction from Western diagnosis such as medical history and CT / MRI examinations
* It has attacked in 7 days
* The assessment of scale of NIHSS:4-24 points
* Age: ≥ 35 years and ≤ 75 years
* Patients or their legal guardians sign informed consent form

Exclusion Criteria:

* The patients with ICH or cerebral hemorrhage or TIA
* It has attacked beyond 7 days
* Patients with stroke history and the mRS ≥ 2 points before this attack
* Mixed type of stroke (infarction after bleeding or bleeding after infarction)
* Patients with cerebral infarction by cardiogenic embolism, blood hypercoagulable state and tunica intima exfoliating
* Patients with serious heart disease;failure of heart or liver or kidney; cancer;digestive tract bleeding
* Women of pregnancy or breast-feeding
* Patients who are taking part in other clinical trials that will influence the results of this study
D: Inclusion Criteria:

* An acute cerebrovascular event (ischemic stroke or intra-cerebral bleeding (ICB)) with the signs and symptoms of an acute stroke according to the World Health Organisation definition of acute stroke14 within the last 12 hours without the need or possibility of a neurosurgical intervention
* No thrombolytic therapy within the first 3 hours (in order to allow the correct comparison with the Swiss cohort of the IST trial
* The informed consent of the patient or, if not possible, of the relatives
* Living at home before the event
* Lack of participation in another trial.

Exclusion Criteria:

* Thrombolytic therapy within the first 3 hours (in order to allow the correct comparison with the Swiss cohort of the IST trial
* No informed consent of the patient or, if not possible, of the relatives
* Not living at home before the event
* Participation in another trial (26 patients were excluded because of TIA with full recovery within 24 hours after the event)

Answer: C